Transcriptomic features of cribriform and intraductal carcinoma of the prostate Z Lone, T Benidir, M Rainey, M Nair, E Davicioni, EA Gibb, S Williamson, ... European Urology Focus 8 (6), 1575-1582, 2022 | 7 | 2022 |
A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma MJ Cortese, W Wei, S Cerdeña, MP Watkins, M Olson, G Jodon, J Kaiser, ... Leukemia & Lymphoma 64 (1), 107-118, 2023 | 4 | 2023 |
Influence of killer immunoglobulin-like receptors and somatic mutations on transplant outcomes in acute myeloid leukemia S Hong, L Rybicki, A Zhang, D Thomas, CM Kerr, J Durrani, MA Rainey, ... Transplantation and cellular therapy 27 (11), 917. e1-917. e9, 2021 | 3 | 2021 |
Separate and combined effects of advanced age and obesity on mammary adipose inflammation, immunosuppression and tumor progression in mouse models of triple negative breast cancer LA Smith, DM Craven, MA Rainey, AJ Cozzo, MS Carson, EM Glenny, ... Frontiers in Oncology 12, 1031174, 2023 | 2 | 2023 |
Egress of resident memory T cells from tissue with neoadjuvant immunotherapy: Implications for systemic anti-tumor immunity MA Rainey, CT Allen, M Craveiro Oral Oncology 146, 106570, 2023 | 1 | 2023 |
Patterns and Risk of CNS Recurrence after R-EPOCH Treatment for Double/Triple Hit Lymphoma MA Sohail, H Li, W Wei, S Cerdena, M Watkins, M Olson, G Jodon, ... Blood 136, 24-25, 2020 | 1 | 2020 |
A multi-center analysis of the impact of dose level of R-EPOCH on outcomes of patients with double/triple-hit B-Cell Lymphoma MJ Cortese, W Wei, S Cerdena, M Watkins, M Olson, G Jodon, J Kaiser, ... Blood 136, 32-34, 2020 | 1 | 2020 |
Can Monosomy 7 be Targeted By Next Generation Cereblon-Modulating Agents? V Adema, CM Kerr, W Walter, S Hutter, Y Nagata, H Awada, ... Blood 134, 1270, 2019 | 1 | 2019 |
Heterogeneous characterization of neutrophilic cells in head and neck cancers M Fay, PE Clavijo, CT Allen Head & Neck, 2024 | | 2024 |
Combined TGFβ/PD-L1 blockade enhances systemic antitumor immunity in head and neck cancer M Rainey, M Craveiro, Y Robbins, C Sievers, CT Allen Cancer Research 83 (7_Supplement), 6422-6422, 2023 | | 2023 |
A genomic classifier for prostate cancer correlates with adverse pathologic features: Transcriptomic features of cribriform and intraductal carcinoma of the prostate. ZM Lone, T Benidir, M Rainey, M Nair, E Davicioni, E Gibb, S Williamson, ... Journal of Clinical Oncology 40 (6_suppl), 268-268, 2022 | | 2022 |
Separate and combined effects of metabolic reprogramming interventions, autophagy inhibition, and carboplatin on murine triple-negative breast cancer cells AJ Cozzo, MF Coleman, CH O'Flanagan, JB Pearce, MA Rainey, ... Cancer Research 79 (13_Supplement), 5278-5278, 2019 | | 2019 |
Advanced age and obesity separately and interactively potentiate triple negative breast cancer progression LA Smith, MA Rainey, NT Sheth, SA Montgomery, SD Hursting Cancer Research 79 (13_Supplement), 2843-2843, 2019 | | 2019 |
Targeting Her2-Positive Breast Cancer Metabolism Through Dietary and Pharmacological Interventions to Improve Therapeutic Efficacy MA Rainey The University of North Carolina at Chapel Hill, 2019 | | 2019 |
Calorie restriction reduces PI3K/Akt signaling and tumorigenic potential in HER2-overexpressing breast cancer LA Smith, MA Rainey, NT Sheth, CH O'Flanagan, LW Bowers, ... Cancer Research 78 (13_Supplement), 379-379, 2018 | | 2018 |
Short-term calorie restriction alters expression of tumor suppressor p21 in HER2-overexpressing breast cancer MA Rainey, LA Smith, CH O'Flanagan, SD Hursting Cancer Research 78 (13_Supplement), 2396-2396, 2018 | | 2018 |
Impact of Short-term Calorie Restriction on HER2-Overexpressing Breast Cancer M Rainey | | 2018 |